Amyris Inc
F:3A01
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samvardhana Motherson International Ltd
NSE:MOTHERSON
|
IN |
|
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
IN |
|
L
|
Leon Technology Co Ltd
SZSE:300603
|
CN |
|
Christian Berner Tech Trade AB
STO:CBTT B
|
SE |
|
H
|
Hong Seng Consolidated Bhd
KLSE:HONGSENG
|
MY |
|
J
|
J C T Ltd
BSE:500223
|
IN |
|
Maha Energy AB
STO:MAHA A
|
SE |
|
Iochpe Maxion SA
BOVESPA:MYPK3
|
BR |
|
Huanlejia Food Group Co Ltd
SZSE:300997
|
CN |
Amyris Inc
Other Equity
Amyris Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amyris Inc
F:3A01
|
Other Equity
-$64.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Other Equity
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Other Equity
-$525m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Other Equity
-$1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Other Equity
-$2.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Albemarle Corp
NYSE:ALB
|
Other Equity
-$334.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
Amyris Inc
Glance View
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
See Also
What is Amyris Inc's Other Equity?
Other Equity
-64.1m
USD
Based on the financial report for Dec 31, 2022, Amyris Inc's Other Equity amounts to -64.1m USD.
What is Amyris Inc's Other Equity growth rate?
Other Equity CAGR 5Y
-9%
Over the last year, the Other Equity growth was -21%. The average annual Other Equity growth rates for Amyris Inc have been -14% over the past three years , -9% over the past five years .
